Related references
Note: Only part of the references are listed.A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease
Faustino Torrico et al.
CLINICAL INFECTIOUS DISEASES (2023)
Furan derivatives impair proliferation and affect ultrastructural organization of Trypanosoma cruzi and Leishmania amazonensis
Aline Araujo Zuma et al.
EXPERIMENTAL PARASITOLOGY (2021)
In vitro study of the trypanocidal activity of anilinophenanthrolines against Trypanosoma cruzi
Aline Araujo Zuma et al.
PARASITOLOGY INTERNATIONAL (2021)
Development of new dinuclear Fe(III) coordination compounds with in vitro nanomolar antitrypanosomal activity
Felipe Figueiroa Moreira et al.
DALTON TRANSACTIONS (2021)
Current trends in the pharmacological management of Chagas disease
Vanessa Ribeiro et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2020)
CYP51 as drug targets for fungi and protozoan parasites: past, present and future
Galina I. Lepesheva et al.
PARASITOLOGY (2018)
Cysteine proteases in protozoan parasites
Jair L. Siqueira-Neto et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Chaetocin-A histone methyltransferase inhibitor-Impairs proliferation, arrests cell cycle and induces nucleolar disassembly in Trypanosoma cruzi
Aline Araujo Zuma et al.
ACTA TROPICA (2017)
Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage
Amanda Fortes Francisco et al.
SCIENTIFIC REPORTS (2016)
Unveiling the effects of berenil, a DNA-binding drug, on Trypanosoma cruzi: implications for kDNA ultrastructure and replication
Aline Araujo Zuma et al.
PARASITOLOGY RESEARCH (2015)
Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
Maria T. Bahia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A Quinoxaline Derivative as a Potent Chemotherapeutic Agent, Alone or in Combination with Benznidazole, against Trypanosoma cruzi
Jean Henrique da Silva Rodrigues et al.
PLOS ONE (2014)
Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1
Natalia Mast et al.
MOLECULAR PHARMACOLOGY (2013)
Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi
Phercyles Veiga-Santos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
A novel triazolic naphthofuranquinone induces autophagy in reservosomes and impairment of mitosis in Trypanosoma cruzi
M. C. Fernandes et al.
PARASITOLOGY (2012)
Fexinidazole: A Potential New Drug Candidate for Chagas Disease
Maria Terezinha Bahia et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Tetrazolium salt based methods for high-throughput evaluation of anti-parasite chemotherapy
Cristina Henriques et al.
ANALYTICAL METHODS (2011)
Effect of topoisomerase inhibitors and DNA-binding drugs on the cell proliferation and ultrastructure of Trypanosoma cruzi
Aline Araujo Zuma et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
MDL28170, a Calpain Inhibitor, Affects Trypanosoma cruzi Metacyclogenesis, Ultrastructure and Attachment to Rhodnius prolixus Midgut
Vitor Ennes-Vidal et al.
PLOS ONE (2011)
Trypanosoma cruzi Epimastigotes Are Able to Store and Mobilize High Amounts of Cholesterol in Reservosome Lipid Inclusions
Miria G. Pereira et al.
PLOS ONE (2011)
Advances in Chagas disease drug development: 2009-2010
Frederick S. Buckner et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
Fexinidazole - A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness
Els Torreele et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Distinct acetylation of Trypanosoma cruzi histone H4 during cell cycle, parasite differentiation, and after DNA damage
Sheila Cristina Nardelli et al.
CHROMOSOMA (2009)
New insights into the morphology of Trypanosoma cruzi reservosome
Celso Sant'Anna et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2008)
Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from β-lapachone
R. F. S. Menna-Barreto et al.
PARASITOLOGY RESEARCH (2007)
Effect of L-leucine methyl ester on growth and ultrastructure of Trypanosoma cruzi
Camila M. Adade et al.
ACTA TROPICA (2007)
Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole
G Benaim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Effect of a β-lapachone-derived naphthoimidazole on Trypanosoma cruzi:: identification of target organelles
RFS Menna-Barreto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi
LR Garzoni et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Differences in the nuclear chromatin among various stages of the life cycle of Trypanosoma cruzi
B Spadiliero et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Share Paper
